s6y

Kiromic Biopharma, Inc.

CIK
1792581
Industry
Biological Products, (No Diagnostic Substances)
Formerly
Kiromic, Inc.

Financials 24

  1. 10-K Annual Report for period ending Dec 31, 2024
  2. 10-Q Quarterly Report for period ending Sep 30, 2024
  3. 10-Q Quarterly Report for period ending Jun 30, 2024
  4. 10-Q Quarterly Report for period ending Mar 31, 2024
  5. 10-K/A Annual Report for period ending Dec 31, 2023
  6. 10-K Annual Report for period ending Dec 31, 2023
  7. 10-Q Quarterly Report for period ending Sep 30, 2023
  8. 10-Q Quarterly Report for period ending Jun 30, 2023
  9. 10-Q Quarterly Report for period ending Mar 31, 2023
  10. 10-K/A Annual Report for period ending Dec 31, 2022

All 24 financials filings

News 94

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K/A Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 94 news filings

Ownership 67

  1. SC 13G/A Major Shareholders
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 67 ownership filings

Prospectus 36

  1. S-1/A General form of registration statement for all companies including face-amount certificate companies
  2. S-1 General form of registration statement for all companies including face-amount certificate companies
  3. RW Registration Withdrawal Request
  4. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  5. S-1 General form of registration statement for all companies including face-amount certificate companies
  6. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  7. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  8. S-1 General form of registration statement for all companies including face-amount certificate companies
  9. RW Registration Withdrawal Request
  10. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

All 36 prospectus filings

Proxies 11

  1. DEF 14A Definitive proxy statements
  2. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. DEF 14A Definitive proxy statements
  5. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  6. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  7. DEF 14A Definitive proxy statements
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. DEF 14A Definitive proxy statements
  10. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

All 11 proxies filings

Other 21

  1. SEC STAFF ACTION
  2. ARS Annual report to security holders
  3. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  4. EFFECT Notice of Effectiveness
  5. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  6. UPLOAD Letter (PDF)
  7. EFFECT Notice of Effectiveness
  8. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  9. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  10. UPLOAD Letter (PDF)

All 21 other filings